about
Novel Anticoagulants in Atrial Fibrillation: Monitoring, Reversal and Perioperative ManagementEffects of Pre-Injury Anti-Platelet Agents on Short-Term Outcome of Patients with Mild Traumatic Brain Injury: A Cohort Study.Impact of stated barriers on proposed warfarin prescription for atrial fibrillation: a survey of Canadian physicians.A sample-to-result system for blood coagulation tests on a microfluidic disk analyzer.Nurses' self-reported time estimation of anticoagulation therapy: a survey of warfarin management in long-term care.Novel Antiplatelet Activity of Minocycline Involves Inhibition of MLK3-p38 Mitogen Activated Protein Kinase Axis.Effects of VKORC1 Genetic Polymorphisms on Warfarin Maintenance Dose Requirement in a Chinese Han Population.Warfarin for prevention of thrombosis among long-term care residents with atrial fibrillation: evidence of continuing low use despite consideration of stroke and bleeding risk.Advantages of a Warfarin Protocol for Long-term Care Pharmacists: a Retrospective Cohort Study.Hypermethylation of brain natriuretic peptide gene is associated with the risk of rheumatic heart disease.Novel oral anticoagulants: a review of new agents.Use of vitamin K antagonist therapy in geriatrics: a French national survey from the French Society of Geriatrics and Gerontology (SFGG).Assessment of Oral Anticoagulant Use in Residents of Long-Term Care Homes: Evidence for Contemporary Suboptimal Use.Tablet splitting of narrow therapeutic index drugs: a nationwide survey in Taiwan.Implementing Guidelines: The Cost and Clinical Impact of Anticoagulants in the UK Atrial Fibrillation Population.Hospitalization for vitamin-K-antagonist-related bleeding: treatment patterns and outcome.Relationship between platelet indices and international normalized ratio in patients with non-valvular atrial fibrillation.Evolvement of a warfarin medication therapy adherence clinic in Malaysia and its impact on international normalised ratio control over timeCharacteristics of patients with thromboembolic disorders on warfarin therapy in resource limited settings
P2860
Q26801895-4B4E325E-8825-40F3-B32A-026E1971028EQ33606616-1D84CDC5-5CB0-4439-9010-03596AA5B0FFQ34087971-FF9A43CC-0044-4C39-8E68-1F2B485E4A4EQ34305196-1BDD87FA-8E01-4465-8F2A-1BDD6E9263DFQ35108548-3C7D7F88-A752-40B7-8303-4DD887BC1752Q36043123-2BDEB6FC-9248-42EE-BE3F-ECCB359CBB24Q36314728-8699A9CE-7AD4-47DE-89B5-21CACF118A3EQ36872957-D216B6BB-529C-4861-8105-AECF2C2C06D1Q37041369-AF018B3C-EB94-47C4-BC53-93C3F9BBAE75Q37589730-9653FFE8-9D46-49C1-B541-8E527C8BD931Q38128173-EAFA45AB-0175-4592-AABD-55908FEAA690Q38156339-81D4962E-5D15-4B11-8459-BD6995AC8760Q39458922-8C1CA776-EBA7-45A0-BA80-6091E8DF7637Q40509651-4384594C-AC5B-48CF-B234-F05306CF46ADQ40832438-4E78A2D2-9BC8-4CDE-966A-9A0E546E56FFQ43650765-6198B122-BDD6-4333-99E9-1EB8F614FF47Q51211791-48B0AD8E-12EB-4189-81C5-01E553CA50ECQ57928331-B1DF0A5D-4979-47A6-A8FA-40E4951B2FA3Q58720888-3F9D6838-5B51-4E10-9390-79CC3B3B9F0C
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Use of warfarin in long-term care: a systematic review
@ast
Use of warfarin in long-term care: a systematic review
@en
Use of warfarin in long-term care: a systematic review
@nl
type
label
Use of warfarin in long-term care: a systematic review
@ast
Use of warfarin in long-term care: a systematic review
@en
Use of warfarin in long-term care: a systematic review
@nl
prefLabel
Use of warfarin in long-term care: a systematic review
@ast
Use of warfarin in long-term care: a systematic review
@en
Use of warfarin in long-term care: a systematic review
@nl
P2093
P2860
P356
P1433
P1476
Use of warfarin in long-term care: a systematic review
@en
P2093
Aarti A Patel
Gregory Reardon
Marjorie Neidecker
Winnie W Nelson
P2860
P2888
P356
10.1186/1471-2318-12-14
P577
2012-04-05T00:00:00Z
P5875
P6179
1049223723